Company Filing History:
Years Active: 1996-1998
Title: Howard R. Higley: Innovator in Renal and Hematologic Treatments
Introduction
Howard R. Higley is a notable inventor based in Mountain View, CA (US). He has made significant contributions to the fields of renal and hematologic treatments, holding 2 patents that showcase his innovative approaches to medical challenges.
Latest Patents
Higley's latest patents include a method of treating renal disease by administering IGF-I and IGFBP-3. This treatment aims to increase renal tubular mass and enhance kidney function in patients suffering from various renal disorders, including acute and chronic renal failure. His second patent focuses on treating immunologic and hematologic disorders with IGFBP-3. This invention addresses immune deficiencies and anemias by administering IGFBP-3, either alone or in combination with insulin-like growth factor (IGF), to improve the patient's condition.
Career Highlights
Higley is associated with Celtrix Pharmaceuticals, Inc., where he has been instrumental in developing innovative treatments. His work has the potential to significantly impact patients with renal and hematologic disorders, providing new avenues for therapy.
Collaborations
Some of Higley's notable coworkers include Christopher A. Maack and Joseph A. Carlino. Their collaborative efforts contribute to the advancement of medical treatments and innovations in their respective fields.
Conclusion
Howard R. Higley's contributions to medical science through his patents reflect his dedication to improving patient outcomes in renal and hematologic health. His innovative methods continue to pave the way for future advancements in treatment options.